NEW YORK CITY, NY / ACCESS Newswire / February 28, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law ...

After two years in the shadows, health stocks are back as a haven for investors navigating economic uncertainty.

Merck & Co. Inc. closed 32.72% below its 52-week high of $134.63, which the company achieved on June 25th.

Significantly extends commercial reach of Growth Direct through expanded global sales channels; enables opportunities for ...

A new government report says that rates for precancerous lesions decreased about 80% among younger women who were screened ...

The FDA’s abrupt decision to cancel next month’s vaccine advisory committee meeting is raising concerns about whether the U.S ...

COLORADO SPRINGS—Sierra Space has announced pharmaceutical giant Merck as its first commercial rideshare partner for the ...

Berenberg analyst Luisa Hector lowered the firm’s price target on Merck (MRK) to $115 from $125 and keeps a Buy rating on the shares. Merck ...

As Merck & Co. hunts for an ideal spot to set up a new commercial facility, Delaware is looking to bolster its odds with a ...

Shares in Rapid Micro Biosystems jumped Friday in premarket trading after it said it signed an agreement with Merck's life science business to distribute its microbiology testing platform. Shares ...

Merck Forest & Farmland Center (MFFC) announces the appointment of Tom O’Handley as its new Senior Director of Development.

Eisai plans to lay off 121 employees in the U.S. A former deputy director of China's drug agency is under investigation by ...